ALLISON CURRAN: Open Payments
NPI 1255467858 · JOLIET, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 16 payments from 10 companies in 2025. Trend: 2023 $613 · 2024 $387 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $42 |
| ABBVIE INC. | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| Aimmune Therapeutics, Inc. | 1 | $31 |
| Organon LLC | 1 | $27 |
| Exact Sciences Corporation | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
Products named: REXULTI, Veozah, QULIPTA, ZENPEP, Rybelsus, NEXPLANON, The Cologuard Plus Collection Kit, NURTEC ODT.
Industry payments across IL — which companies pay providers there.
